Miroševič Špela, Khandelwal Shivang, Sušjan Petra, Žakelj Nina, Gosar David, Forstnerič Vida, Lainšček Duško, Jerala Roman, Osredkar Damjan
Department of Family Medicine, Medical Faculty Ljubljana, University of Ljubljana, 1000 Ljubljana, Slovenia.
Department of Bioscience and Bioengineering, Indian Institute of Technology Jodhpur, Jodhpur 342027, Rajasthan, India.
Int J Mol Sci. 2022 Oct 19;23(20):12564. doi: 10.3390/ijms232012564.
The CTNNB1 Syndrome is a rare neurodevelopmental disorder associated with developmental delay, intellectual disability, and delayed or absent speech. The aim of the present study is to systematically review the available data on the prevalence of clinical manifestations and to evaluate the correlation between phenotype and genotype in published cases of patients with CTNNB1 Syndrome. Studies were identified by systematic searches of four major databases. Information was collected on patients' genetic mutations, prenatal and neonatal problems, head circumference, muscle tone, EEG and MRI results, dysmorphic features, eye abnormalities, early development, language and comprehension, behavioral characteristics, and additional clinical problems. In addition, the mutations were classified into five groups according to the severity of symptoms. The study showed wide genotypic and phenotypic variability in patients with CTNNB1 Syndrome. The most common moderate-severe phenotype manifested in facial dysmorphisms, microcephaly, various motor disabilities, language and cognitive impairments, and behavioral abnormalities (e.g., autistic-like or aggressive behavior). Nonsense and missense mutations occurring in exons 14 and 15 were classified in the normal clinical outcome category/group because they had presented an otherwise normal phenotype, except for eye abnormalities. A milder phenotype was also observed with missense and nonsense mutations in exon 13. The autosomal dominant CTNNB1 Syndrome encompasses a wide spectrum of clinical features, ranging from normal to severe. While mutations cannot be more generally categorized by location, it is generally observed that the C-terminal protein region (exons 13, 14, 15) correlates with a milder phenotype.
β-连环蛋白1综合征是一种罕见的神经发育障碍,与发育迟缓、智力残疾以及言语延迟或缺失有关。本研究的目的是系统回顾关于临床表现患病率的现有数据,并评估已发表的β-连环蛋白1综合征患者病例中表型与基因型之间的相关性。通过对四个主要数据库进行系统检索来确定研究。收集了患者的基因突变、产前和新生儿问题、头围、肌张力、脑电图和磁共振成像结果、畸形特征、眼部异常、早期发育、语言和理解能力、行为特征以及其他临床问题等信息。此外,根据症状严重程度将突变分为五组。研究表明,β-连环蛋白1综合征患者存在广泛的基因型和表型变异性。最常见的中重度表型表现为面部畸形、小头畸形、各种运动障碍、语言和认知障碍以及行为异常(如自闭症样或攻击性行为)。外显子14和15中发生的无义突变和错义突变被归类为正常临床结果类别/组,因为除了眼部异常外,它们表现出其他方面正常的表型。在外显子13中存在错义突变和无义突变时也观察到了较轻的表型。常染色体显性β-连环蛋白1综合征涵盖了从正常到严重的广泛临床特征。虽然突变不能更普遍地按位置分类,但一般观察到蛋白质的C末端区域(外显子13、14、15)与较轻的表型相关。